<DOC>
	<DOC>NCT01701193</DOC>
	<brief_summary>The purpose of this study is to determine whether an amino acid is an effective treatment to prevent abdominal/pelvic scar tissue.</brief_summary>
	<brief_title>A Phase I Study For the Reduction of Scar Tissue in Adult Females Undergoing Surgery for an Ectopic Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Pregnancy, Ectopic</mesh_term>
	<criteria>Subjects are female Subjects are 18 years of age or older at the time of consent Subjects have a BMI between 17 and 35 Subjects or subject's legal representative must have signed informed consent form Subjects have a preoperative diagnosis of an ectopic pregnancy with ultrasonographic confirmation of absence of an intrauterine ectopic pregnancy Subjects whose BMI is outside the range of 17 35 Subjects participating in another clinical trial with a drug or a device Subjects who have participated in a clinical trial with a drug or device within 30 days prior to this study Subjects with suspected or diagnosed coexisting intrauterine pregnancy Subjects with suspected intraabdominal infection Subjects who are immunocompromised Subjects diagnosed with cancer Subjects treated with hemostatic agents (e.g. fibrin sealant, collagen, oxidized cellulose) Subjects treated with adhesion prevention agents other than the AntiAdhesion Product (APP) (e.g. Intergel® Adhesion Prevention Solution, Seprafilm® Membrane) Subjects taking antiepileptic medications Subjects who have been treated with Methotrexate or other chemotherapeutic agents</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>